
Biodesix BDSX
€ 12.97
2.03%
Quartalsbericht 2026-Q1
hinzugefügt 23.05.2026
Biodesix P/CF 2011-2026 | BDSX
P/CF Jährlich Biodesix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.84 | -0.0944 | -5.78 | -1.62 | -5.13 | -4.56 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.0944 | -5.78 | -3.67 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
-5.18 | $ 17.63 | -0.23 % | $ 543 M | ||
|
Guardant Health
GH
|
-72.7 | $ 124.23 | 3.65 % | $ 15.6 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 117.53 | 3.23 % | $ 9.69 B | ||
|
Agilent Technologies
A
|
28.3 | $ 116.72 | 1.43 % | $ 35.5 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.8 | - | $ 7.96 M | ||
|
Celcuity
CELC
|
-35 | $ 136.22 | 1.46 % | $ 6.37 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Illumina
ILMN
|
19.6 | $ 146.22 | 0.69 % | $ 23.2 B | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 9.53 | 4.56 % | $ 12.7 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 21.58 | 9.6 % | $ 626 M | ||
|
Aspira Women's Health
AWH
|
-0.0975 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 21.92 | 1.76 % | $ 1.17 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 100.07 | 0.01 % | $ 6.75 B | ||
|
Global Cord Blood Corporation
CO
|
0.495 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-23.5 | - | - | $ 7.1 B | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 111.16 | 0.89 % | $ 22.9 B | ||
|
NeoGenomics
NEO
|
284 | $ 9.52 | 2.7 % | $ 1.22 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 19.5 | 2.42 % | $ 436 M | ||
|
Natera
NTRA
|
-12.3 | $ 199.69 | -0.61 % | $ 19.7 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 161.9 | 3.3 % | $ 8.02 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Personalis
PSNL
|
-5.75 | $ 9.0 | 0.67 % | $ 803 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 433.87 | 1.11 % | $ 12.5 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 3.92 | 1.82 % | $ 363 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 26.84 | -0.46 % | $ 25.5 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.45 | 0.24 % | $ 269 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.33 | -5.67 % | $ 5.35 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 65.83 | 1.49 % | $ 3.94 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 262.38 | 1.52 % | $ 21.8 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 452.57 | 0.96 % | $ 171 B | ||
|
Waters Corporation
WAT
|
30.1 | $ 345.75 | 2.1 % | $ 20.6 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.64 | -0.94 % | $ 230 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.37 | 2.52 % | $ 2.03 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 195.52 | 1.37 % | $ 21.7 B |